InvestorsHub Logo
Followers 3
Posts 526
Boards Moderated 0
Alias Born 12/24/2006

Re: hotstocks-agent post# 146

Thursday, 01/25/2007 7:28:39 PM

Thursday, January 25, 2007 7:28:39 PM

Post# of 14966
December 13, 2005 - 9:01 AM EST


Founder of NatureWell, Donald Brucker, Dies at Age 72
SAN DIEGO, Dec. 13 /PRNewswire-FirstCall/ -- NatureWell, Incorporated (the 'Company') -- (OTC Bulletin Board: NAWL) announced today that the Company's founder, Dr. Donald Brucker, died on Saturday, December 3, 2005 due to complications following a stroke. Dr. Brucker was 72 years old and was survived by his wife DeDe, six children and seven grandchildren. He served as director for the Company and as its Senior Vice President of Research and Development. There are no current plans to fill either position at this time.

Commenting on Dr. Brucker's passing, James R. Arabia, Chairman and Chief Executive Officer of the Company, stated: Our most heartfelt condolences go out to Don's family. In addition to being a respected co-worker and mentor, Don was my friend and I will miss him greatly. I sincerely wish that he could have stayed with us long enough to see the fulfillment of the dreams that both he and I shared for NatureWell. Don's legacy at NatureWell lies in the fact that he was instrumental in providing the Company with numerous product inventions along with a proprietary methodology for future product development. His inventions and ideas leave NatureWell well-positioned to develop and market innovative products for many years to come. Don left NatureWell prepared for the future and we remain motivated and committed to the fulfillment of his dreams for the Company.

The Company currently markets its migraine relief product under the name MigraSpray, www.migraspray.com, which is a patented spray formulation, delivered sublingually, containing the herb feverfew, intended to provide fast relief and prevention from pain and other symptoms associated with migraine headaches. NatureWell is an emerging company engaged in the development, marketing and licensing of unique, proprietary healthcare products.

Statements made in this news release should be considered forward-looking and subject to various risks and uncertainties. Such forward-looking statements are based on management's beliefs and assumptions regarding information currently available, and are made pursuant to the 'safe harbor' provisions of the federal securities laws. The Company's actual performance and results could differ materially from those expressed in the forward-looking statements due to certain risks and uncertainties that could materially impact the Company in an adverse fashion and are only predictions of future results, and there can be no assurance that the Company's actual results will not materially differ from those anticipated in these forward-looking statements. Such risks and uncertainties, include, but are not limited to, the Company's ability to secure adequate financing, the Company's ability to ship its products in a timely fashion, volume and timing of orders received, interruption of the manufacturing or distribution of the Company's products or of the supplies or ingredients used to manufacture the Company's products, the effectiveness of the Company's products and consumer perception as to the effectiveness of the products, competitive pricing pressures and the Company's ability to anticipate changes in the market. The Company has no obligation to publicly update or revise any of the forward- looking statements that may be in this news release.

SOURCE NatureWell, Incorporated



Source: PR Newswire (December 13, 2005 - 9:01 AM EST)

News by QuoteMedia
www.quotemedia.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMMJ News